Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to include a new facility name, location details, and a list of publications related to durvalumab and tremelimumab, while removing several location-related terms and previous publication references.SummaryDifference9%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference2%
- Check44 days agoChange DetectedThe web page has been updated from version v2.16.5 to v2.16.6.SummaryDifference0.1%
- Check51 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.